CRepHS Research News

Compadre, van Biljon publish a co-first author article in Clinical Cancer Research

Amanda Compadre, MD, and Lily van Biljon recently published an article in Clinical Cancer Research titled “RAD51 Foci as a Biomarker Predictive of Platinum Chemotherapy Response in Ovarian Cancer.” This paper demonstrates that RAD51 foci are a robust marker of platinum chemotherapy response and survival in ovarian cancer. This research was led by Mary (Maggie) Mullen, MD.

Read their original work: